Study on the Oxidative Stress in the Ovaries of a Rat Model of Polycystic Ovary

GONG Jin, WU Dong-bo, ZHANG Lan-lan. et al

Abstract

To establish a pathological animal model of polycystic ovary (PCO) by letrozole in rats. Investigate whether PCO were mediated by the effect of oxidative stress by measuring oxidative stress levels in this cohort of rats with PCO* and proceed a new way of treatment for polycystic ovary syndrom (PCOS). Methods 90 SI) female rats aged 6 weeks were randomly divided into two groups, including a control group of 45 rats that received vehicle only Cl% aqueous solution of carboxmethlycellulose (CMC), 1 mL/d] once daily orally (p. o. ), and an experimental group of 45 rats, which were administered letrozole at concentrations of 1 mg/kg p. o. dissolved in 1 % CMC (1 mL/d) once daily. The treatment period was 28 d. During this period, vaginal smears were collected daily for estrus cycle determination and body masses were measured every 7 d. On the day subsequent to the last letrozole dose administration, rats were killed; Uteri and ovaries were then excised and weighed for the calculation of organ indexes. Serum hormone levels, SHBG and histologic changes in the ovaries were examined. Then testosterone free index (FAI) was calculated. Oxidant status was evaluated by determination of ovarian total oxidant status (TOS), malondialdehyde (MDA) concentration and intracellular reactive oxygen species (ROS) level, while antioxidant status was evaluated by determination of total antioxidant status (TAS) and superoxide dismutase (SOI)) concentration. Results Vaginal smear test showed the estrus cycle began to disappear from day 12 to day 15. A statistically significant difference in growth curves, ovarian weights, uterine weights and organ indexes between the groups were also observed. In rats with PCO serum testosterone (T), follicle-stimulating hormone (FSH) concentrations and free androgen index (FAI) were significantly increased compared with the control group (rats without PCO). However, rats with PCO had decreased levels of estrogen (E2), luteinizing hormone (LH), and progesterone (P) compared with the control group. In a rat model of PCO achieved via letrozole,it was found that the levels of TOS, MDA, oxidative stress index (OSI) and intracellular ROS were significantly increased, while the TAS level, SOD content were significantly decreased in the ovary homogenates  [...]

 

Keywords: PCOS, RatLetrozole, ROSO xidative stress 


Full Text:

PDF


References


Azziz R. Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocr Metab.2004 ;89(6) ;2745-2749.

Boyle JA. Cunningham J. O, Dea K. et al. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin. Australia. Med J Aust,2012; 196( 1):62-66.

Agrawal R, Sharma S, Bekir J, et al. Prevalence of polycystic ovaries and polycystic оч'агу syndrome in lesbian women compared with heterosexual women. Fertil Steril, 2004; 82(5) ; 1352-1357.

Norman RJ. Dewailly D. Legro RS, et al. Polycystic ovary syndrome. Lancet*2007;370(9588): 685-697.

Kafali Н, Iriadam М, Ozardali I, et al. Letrozole-induced polycystic ovaries in the rat; a new model for cystic ovarian disease. Arch Med Res,2004;35(2); 103-108.

Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem,2005;38( 12): 1103-1111. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem,2004 ;37(4 ) :277-285.

Rizzo A. Roscino M. Binetti F. et al. Roles of reactive oxygen species in female reproduction. Reprod Domest Anim.2012;47 (2):344-352.

Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature.2000;408(6809) :239-247.

Agarwal A. Gupta S. Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol, 2005; 3 ( 28 ); 1- 21.

Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction; a review. Reprod Biol Endocrinol,2012? 10(49); 1-31. 247 ]Й[)

Sabuncu T, Vural H. Harma M. et al. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem,2001;34(5) :407-413.

Fenkci V, Fenkci S, Yilmazer M, et al. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Sterib2003;80(1) :123-127.

Gonzalez F. Rote NS, Minium J, et al. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocr Metab.2006 ;91 ( 1) :336-340.

Puddu P. Puddu GM. Cravero E. et al. The molecular sources of reactive oxygen species in hypertension. Blood Pressure, 2008;17(2):70-77.

Oyawoye O. Gadir AA, Garner A, et al. Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod, 2003; 18 ( 11 ):

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic оч'агу syndrome. Hum Reprod,2004; 19( 1);41-47.


Refbacks

  • There are currently no refbacks.